Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Pediatric | 3 | 2024 | 1014 | 1.070 |
Why?
|
| Endothelium | 2 | 2022 | 764 | 0.740 |
Why?
|
| Shock, Septic | 3 | 2020 | 761 | 0.660 |
Why?
|
| Lung Injury | 1 | 2022 | 424 | 0.580 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2020 | 558 | 0.570 |
Why?
|
| Sepsis | 2 | 2020 | 2592 | 0.530 |
Why?
|
| Respiration, Artificial | 1 | 2024 | 2622 | 0.420 |
Why?
|
| Mental Processes | 1 | 2012 | 245 | 0.360 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 3484 | 0.340 |
Why?
|
| Liver Failure, Acute | 1 | 2011 | 181 | 0.330 |
Why?
|
| Social Behavior | 1 | 2012 | 1131 | 0.260 |
Why?
|
| Bipolar Disorder | 2 | 2012 | 5078 | 0.240 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2011 | 930 | 0.210 |
Why?
|
| Antitubercular Agents | 1 | 2011 | 1373 | 0.210 |
Why?
|
| Emotions | 1 | 2012 | 2734 | 0.180 |
Why?
|
| Methylphenidate | 3 | 2010 | 488 | 0.180 |
Why?
|
| Multiple Organ Failure | 1 | 2022 | 386 | 0.160 |
Why?
|
| Angiopoietin-1 | 1 | 2019 | 122 | 0.150 |
Why?
|
| Angiopoietin-2 | 1 | 2019 | 172 | 0.150 |
Why?
|
| Child | 14 | 2024 | 79806 | 0.140 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 5 | 2010 | 3701 | 0.140 |
Why?
|
| ROC Curve | 1 | 2024 | 3568 | 0.130 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2020 | 347 | 0.130 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 14495 | 0.130 |
Why?
|
| Central Nervous System Stimulants | 3 | 2010 | 1174 | 0.130 |
Why?
|
| Blood Proteins | 1 | 2020 | 1173 | 0.120 |
Why?
|
| Epilepsy | 5 | 2010 | 3267 | 0.120 |
Why?
|
| Cell Adhesion Molecules | 1 | 2020 | 1602 | 0.110 |
Why?
|
| Prognosis | 3 | 2024 | 29658 | 0.100 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2020 | 1004 | 0.100 |
Why?
|
| Child, Preschool | 6 | 2024 | 42063 | 0.100 |
Why?
|
| Adolescent | 9 | 2024 | 87810 | 0.100 |
Why?
|
| Wechsler Scales | 1 | 2012 | 257 | 0.100 |
Why?
|
| Ethambutol | 1 | 2011 | 59 | 0.100 |
Why?
|
| Coccidioidomycosis | 1 | 2011 | 37 | 0.090 |
Why?
|
| Infant | 3 | 2024 | 36060 | 0.090 |
Why?
|
| Pyrazinamide | 1 | 2011 | 60 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 1881 | 0.090 |
Why?
|
| Fluconazole | 1 | 2011 | 155 | 0.090 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2019 | 1717 | 0.090 |
Why?
|
| Propylamines | 1 | 2010 | 161 | 0.090 |
Why?
|
| Isoniazid | 1 | 2011 | 283 | 0.080 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2010 | 186 | 0.080 |
Why?
|
| Rifampin | 1 | 2011 | 340 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2024 | 54303 | 0.080 |
Why?
|
| Risk Assessment | 2 | 2024 | 24123 | 0.070 |
Why?
|
| Antifungal Agents | 1 | 2011 | 749 | 0.070 |
Why?
|
| Peptide Fragments | 1 | 2019 | 5125 | 0.070 |
Why?
|
| Hospital Mortality | 1 | 2020 | 5425 | 0.060 |
Why?
|
| Humans | 17 | 2024 | 760621 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15840 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2012 | 6015 | 0.060 |
Why?
|
| Male | 10 | 2024 | 359744 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 12626 | 0.050 |
Why?
|
| Memory | 1 | 2012 | 2179 | 0.050 |
Why?
|
| Attention | 1 | 2012 | 2387 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 6498 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2011 | 2985 | 0.050 |
Why?
|
| Female | 9 | 2024 | 391270 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 7021 | 0.040 |
Why?
|
| Time Factors | 1 | 2020 | 40165 | 0.040 |
Why?
|
| Mental Disorders | 2 | 2007 | 6796 | 0.040 |
Why?
|
| Critical Pathways | 1 | 2020 | 475 | 0.030 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 651 | 0.030 |
Why?
|
| Seizures | 1 | 2007 | 2917 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2012 | 22053 | 0.030 |
Why?
|
| Pediatrics | 1 | 2007 | 3586 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 39261 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 1854 | 0.020 |
Why?
|
| Anticonvulsants | 2 | 2010 | 1879 | 0.020 |
Why?
|
| Critical Illness | 1 | 2022 | 2709 | 0.020 |
Why?
|
| Amphetamines | 1 | 2007 | 143 | 0.020 |
Why?
|
| Hyperkinesis | 1 | 2007 | 89 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2007 | 500 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2019 | 8555 | 0.020 |
Why?
|
| Medical Records | 1 | 2010 | 1407 | 0.020 |
Why?
|
| Length of Stay | 1 | 2019 | 6479 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2932 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 2061 | 0.010 |
Why?
|
| Affective Symptoms | 1 | 2007 | 416 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2008 | 1428 | 0.010 |
Why?
|
| Aggression | 1 | 2007 | 745 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2852 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2020 | 80372 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2020 | 65017 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7818 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 1190 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2010 | 12427 | 0.010 |
Why?
|
| Comorbidity | 1 | 2007 | 10551 | 0.010 |
Why?
|
| Adult | 2 | 2020 | 219994 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 18416 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 17790 | 0.000 |
Why?
|
| Risk Factors | 1 | 2007 | 74359 | 0.000 |
Why?
|
| Animals | 1 | 2008 | 167963 | 0.000 |
Why?
|
Concepts
(94)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(12)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_